NovaBridge Biosciences (NBP) Share-based Compensation (2019 - 2025)

NovaBridge Biosciences (NBP) reported Share-based Compensation of $3.9 million for Q4 2025, up 378.76% year-over-year from $824000.0 in Q4 2024, and up 170.76% quarter-over-quarter from $1.5 million in Q3 2025.

NovaBridge Biosciences (NBP) Share-based Compensation (2019 - 2025) Analysis & Trends

NovaBridge Biosciences (NBP) has 4 years of Share-based Compensation data on file, last reported at $3.9 million in Q4 2025.

  • Share-based Compensation for Q4 2025 came in at $3.9 million, up 378.76% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.5 million (down 83.59% YoY), and the FY2025 annual result was $6.0 million, up 406.52% from the prior year.
  • Share-based Compensation grew to $3.9 million in Q4 2025 per NBP's latest filing, from $1.5 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $3.9 million in Q4 2025 and troughed at $318000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 305,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 166.40 Mn
9 Abivax 90.15 Bn 90.15 Bn - 26.47 Mn
10 NovaBridge Biosciences 328.19 Mn 117.34 Mn - 3.95 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.95 Mn
Dec 31, 2025 3.95 Mn
Sep 30, 2025 1.46 Mn
Sep 30, 2025 1.46 Mn
Dec 31, 2024 824,000.00
Dec 31, 2024 824,000.00
Sep 30, 2024 318,000.00
Sep 30, 2024 318,000.00
Dec 31, 2020 15.22 Mn
Dec 31, 2020 15.22 Mn
Sep 30, 2020 23.52 Mn
Sep 30, 2020 23.52 Mn
Dec 31, 2019 -52.05 Mn
Dec 31, 2019 -52.05 Mn